跳至主要内容
临床试验/NCT06276114
NCT06276114已完成不适用

Comparison of Intravascular Coronary Lithotripsy and Excimer Laser Coronary Atherectomy for Severe Stent Underexpansion: the Multicenter IVL- ELCA DRAGON Registry

Medical University of Silesia20 个研究点 分布在 2 个国家目标入组 121 人开始时间: 2020年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
121
试验地点
20
主要终点
The primary efficacy endpoint was device success

研究概览

简要总结

The IVL- ELCA DRAGON Registry is a multicenter study that enrolled consecutive patients with stent underexpansion treated with IVL ora ELCA in high-volume PCI centers.

The primary efficacy endpoint was device success (technical success with a final stent expansion ≥ 80%). Thirty days device-oriented composite endpoint (DOCE: cardiac death, target lesion revascularization, or target vessel myocardial infarction) was the secondary endpoint.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

The primary efficacy endpoint was device success

时间窗: During procedure

Technical success with a final stent expansion ≥80%.

次要结局

  • Device-oriented composite endpoint (DOCE)(Thirty days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Wojciech Wańha

MD, PhD, Prof. Ass.

Medical University of Silesia

研究点 (20)

Loading locations...

相似试验

IVL vs ELCA for Stent Underexpantsion (IVL-ELCA... | 临床试验